Safety and Dose Finding Study of Different MOD-4023 Dose Levels Compared to Daily R-human Growth Hormone (hGH) Therapy in Pre-pubertal Growth Hormone Deficient Children

Trial Profile

Safety and Dose Finding Study of Different MOD-4023 Dose Levels Compared to Daily R-human Growth Hormone (hGH) Therapy in Pre-pubertal Growth Hormone Deficient Children

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Apr 2016

At a glance

  • Drugs Somatropin (Primary)
  • Indications Somatotropin deficiency
  • Focus Therapeutic Use
  • Sponsors OPKO Health
  • Most Recent Events

    • 04 Apr 2016 Results assessing IGF-1 from this and other trial (see profile 246228) presented at The 98th Annual Meeting of the Endocrine Society
    • 04 Apr 2016 Results of a pharmacokinetic and pharmacodynamic modeling presented at The 98th Annual Meeting of the Endocrine Society
    • 24 Mar 2016 According to OPKO media release, data from this study will be presented in an oral presentation at the Endocrine Society's 98th Annual Meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top